These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19031539)

  • 1. Cyclosporine in acute myocardial infarction.
    Hoffman I
    N Engl J Med; 2008 Nov; 359(21):2287; author reply 2288-9. PubMed ID: 19031539
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine in acute myocardial infarction.
    Ibanez B; Badimon JJ
    N Engl J Med; 2008 Nov; 359(21):2287; author reply 2288-9. PubMed ID: 19031538
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine in acute myocardial infarction.
    Ryding AD
    N Engl J Med; 2008 Nov; 359(21):2287-8; author reply 2288-9. PubMed ID: 19031540
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
    Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
    Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to take myocardial reperfusion injury seriously.
    Hausenloy DJ; Yellon DM
    N Engl J Med; 2008 Jul; 359(5):518-20. PubMed ID: 18669431
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine in acute myocardial infarction.
    Theruvath TP; Lemasters JJ
    N Engl J Med; 2008 Nov; 359(21):2286; author reply 2288-9. PubMed ID: 19020331
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of cyclosporine on reperfusion injury in acute myocardial infarction.
    Piot C; Croisille P; Staat P; Thibault H; Rioufol G; Mewton N; Elbelghiti R; Cung TT; Bonnefoy E; Angoulvant D; Macia C; Raczka F; Sportouch C; Gahide G; Finet G; André-Fouët X; Revel D; Kirkorian G; Monassier JP; Derumeaux G; Ovize M
    N Engl J Med; 2008 Jul; 359(5):473-81. PubMed ID: 18669426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
    Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
    J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion.
    Prasad A; Stone GW; Holmes DR; Gersh B
    Circulation; 2009 Nov; 120(21):2105-12. PubMed ID: 19933949
    [No Abstract]   [Full Text] [Related]  

  • 10. Fighting the "fire" of myocardial reperfusion injury: how to define success?
    Wu KC
    J Am Coll Cardiol; 2009 Feb; 53(8):730-1. PubMed ID: 19232908
    [No Abstract]   [Full Text] [Related]  

  • 11. [Myocardial infarction aborted by rapid percutaneous coronary intervention].
    van Etten J; Verheugt FW
    Ned Tijdschr Geneeskd; 2009; 153():A467. PubMed ID: 19785883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxygen therapy: a Bayesian breath of fresh air for myocardial salvage.
    Ly HQ; Kip KE; Tanguay JF
    Circ Cardiovasc Interv; 2009 Oct; 2(5):363-5. PubMed ID: 20031744
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine in acute myocardial infarction.
    Rossi JS; Simpson RJ
    N Engl J Med; 2008 Nov; 359(21):2286-7; author reply 2288-9. PubMed ID: 19031537
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial reperfusion injury.
    Ramaraj R
    N Engl J Med; 2007 Dec; 357(23):2408; author reply 2409-10. PubMed ID: 18057349
    [No Abstract]   [Full Text] [Related]  

  • 15. [Postconditioning in acute myocardial infarction: Primary angioplasty revisited?].
    Monassier JP; Shayne J; Sommier JM; Schultz R; Ider O
    Ann Cardiol Angeiol (Paris); 2010 Nov; 59(5):294-305. PubMed ID: 20889138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial protection: is primary PCI enough?
    Hausenloy DJ; Yellon DM
    Nat Clin Pract Cardiovasc Med; 2009 Jan; 6(1):12-3. PubMed ID: 18852713
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reperfusion in myocardial infarction: a two-edged sword].
    Emanuelsson H; Währborg P
    Lakartidningen; 1996 Mar; 93(12):1112-5. PubMed ID: 8649073
    [No Abstract]   [Full Text] [Related]  

  • 19. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits.
    Pagel PS; Krolikowski JG
    Anesth Analg; 2009 Apr; 108(4):1076-82. PubMed ID: 19299764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of pre and post conditioning to prevent cardiac ischemic sequelae.
    Meijer RC; Kappetein AP; Serruys PW; Bogers JJ
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):21-3. PubMed ID: 19618594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.